Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Jun 2026 for Acumen Pharmaceuticals, Inc., €26k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Derrell Porter: trading record in brief
All filings by Derrell Porter on record concern Acumen Pharmaceuticals, Inc. Between 15 June 2026 and 17 June 2026, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 17 June 2026, reports a transaction of €26k in Acumen Pharmaceuticals, Inc. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Derrell Porter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
13,040 shares@ US$2.32540.015% mcap100.0% of flowCommonSEC144:0001950047-26-006245
12,800 shares@ US$2.3256CommonSEC144:0001950047-26-006235
6,460 shares@ US$2.345CommonSEC144:0001950047-26-006161
3 of 3 declarations
